Katarina Lalić

4.7k total citations
75 papers, 1.0k citations indexed

About

Katarina Lalić is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Katarina Lalić has authored 75 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Endocrinology, Diabetes and Metabolism, 26 papers in Surgery and 13 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Katarina Lalić's work include Diabetes, Cardiovascular Risks, and Lipoproteins (14 papers), Diabetes Management and Research (13 papers) and Pancreatic function and diabetes (13 papers). Katarina Lalić is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (14 papers), Diabetes Management and Research (13 papers) and Pancreatic function and diabetes (13 papers). Katarina Lalić collaborates with scholars based in Serbia, Czechia and Poland. Katarina Lalić's co-authors include Nebojša Lalić, Aleksandra Jotić, Ljiljana Lukić, Tanja Miličić, N. Rajković, Marija Maćešić, Ljiljana Popović, Sanja Stanković, Aleksandra Kezić and Jelena P. Seferović and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American College of Cardiology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Katarina Lalić

70 papers receiving 986 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katarina Lalić Serbia 16 296 284 258 196 168 75 1.0k
Harvest F. Gu China 24 319 1.1× 565 2.0× 269 1.0× 170 0.9× 182 1.1× 75 1.5k
Po‐Shiuan Hsieh Taiwan 19 283 1.0× 298 1.0× 369 1.4× 318 1.6× 169 1.0× 58 1.1k
Thiago Bruder‐Nascimento United States 18 244 0.8× 259 0.9× 257 1.0× 172 0.9× 203 1.2× 47 964
Avshalom Leibowitz Israel 18 274 0.9× 256 0.9× 242 0.9× 117 0.6× 117 0.7× 58 1.1k
Ming-Sheng Zhou China 21 223 0.8× 277 1.0× 341 1.3× 173 0.9× 134 0.8× 54 1.2k
Rocío Guzmán‐Ruiz Spain 17 150 0.5× 351 1.2× 420 1.6× 313 1.6× 278 1.7× 40 1.2k
Xiao-Min Liu China 18 227 0.8× 302 1.1× 139 0.5× 98 0.5× 207 1.2× 49 883
PP Nawroth Germany 15 378 1.3× 279 1.0× 344 1.3× 151 0.8× 167 1.0× 44 1.3k
Fabrizio Ceci Italy 24 433 1.5× 216 0.8× 324 1.3× 413 2.1× 227 1.4× 54 1.4k

Countries citing papers authored by Katarina Lalić

Since Specialization
Citations

This map shows the geographic impact of Katarina Lalić's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katarina Lalić with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katarina Lalić more than expected).

Fields of papers citing papers by Katarina Lalić

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katarina Lalić. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katarina Lalić. The network helps show where Katarina Lalić may publish in the future.

Co-authorship network of co-authors of Katarina Lalić

This figure shows the co-authorship network connecting the top 25 collaborators of Katarina Lalić. A scholar is included among the top collaborators of Katarina Lalić based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katarina Lalić. Katarina Lalić is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Miličić, Tanja, Aleksandra Jotić, Katarina Lalić, et al.. (2025). Insulin Secretion and Insulin Sensitivity Change in Different Stages of Adult-Onset Type 1 Diabetes: A Cross-Sectional Study. Journal of Clinical Medicine. 14(4). 1109–1109. 1 indexed citations
2.
Lalić, Nebojša, Aleksandra Jotić, Ljiljana Lukić, et al.. (2024). Glucose lowering drug or strategy dependent impact of weight reduction on the prevention of CVD outcomes in Type 2 diabetes: a systematic review of CVOTs. Diabetes Research and Clinical Practice. 216. 111816–111816. 1 indexed citations
3.
Todorović, Jovana, et al.. (2024). Management of Pregnancy in a Patient with Familial Hypercholesterolemia and Previous Myocardial Infarction—Treatment with LDL Apheresis: A Case Report. SHILAP Revista de lepidopterología. 7(2). 39–39. 1 indexed citations
4.
Madan, Nidhi, et al.. (2021). AGE AND SEX-BASED DIFFERENCES IN CARDIOVASCULAR OUTCOMES OF SGLT2 INHIBITORS. Journal of the American College of Cardiology. 77(18). 871–871. 1 indexed citations
5.
Tricò, Domenico, Alessandro Mengozzi, Lorenzo Nesti, et al.. (2019). Circulating palmitoleic acid is an independent determinant of insulin sensitivity, beta cell function and glucose tolerance in non-diabetic individuals: a longitudinal analysis. Diabetologia. 63(1). 206–218. 46 indexed citations
6.
Češka, R, Gustavs Latkovskis, М. В. Ежов, et al.. (2019). The Impact of the International Cooperation On Familial Hypercholesterolemia Screening and Treatment: Results from the ScreenPro FH Project. Current Atherosclerosis Reports. 21(9). 36–36. 10 indexed citations
7.
Madan, Nidhi, Biljana Parapid, Laurence Sperling, et al.. (2019). P2482Sex-based differences in cardioprotective role of SGLT-2 inhibitors in patients with type 2 diabetes mellitus. European Heart Journal. 40(Supplement_1).
8.
Siméon, S., Ziad A. Massy, Kurt Højlund, et al.. (2018). Renal function markers and insulin sensitivity after 3 years in a healthy cohort, the EGIR-RISC study. BMC Nephrology. 19(1). 124–124. 1 indexed citations
9.
Lalić, Katarina, Aleksandra Jotić, Tanja Miličić, et al.. (2018). The inflammatory and hemostatic cardiovascular risk markers during acute hyperglycemic crisis in type 1 and type 2 diabetes. Journal of Medical Biochemistry. 38(2). 126–133. 9 indexed citations
10.
Martinović, Tamara, Igor Pantić, Katarina Lalić, et al.. (2018). Unusual shape and structure of lymphocyte nuclei is linked to hyperglycemia in type 2 diabetes patients. Tissue and Cell. 52. 92–100. 10 indexed citations
11.
Lalić, Katarina, N. Rajković, Ljiljana Popović, et al.. (2018). The effects of 3-year statin therapy and the achievement of LDL cholesterol target values in familial hypercholesterolemia patients: An experience from Serbia. Atherosclerosis. 277. 298–303. 9 indexed citations
12.
Seferović, Jelena P., Milorad Tešić, Petar Seferović, et al.. (2018). Increased left ventricular mass index is present in patients with type 2 diabetes without ischemic heart disease. Scientific Reports. 8(1). 926–926. 28 indexed citations
13.
Lalić, Katarina, et al.. (2017). The Importance of the Bolus Calculator Use for Improving Glycemic Control in Patients on the Insulin Pump Therapy. Scripta Medica. 48(1). 45–52. 1 indexed citations
14.
Jotić, Aleksandra, Tanja Miličić, Vladimir Kostić, et al.. (2015). Decreased Insulin Sensitivity and Impaired Fibrinolytic Activity in Type 2 Diabetes Patients and Nondiabetics with Ischemic Stroke. International Journal of Endocrinology. 2015. 1–7. 10 indexed citations
15.
Parapid, Biljana, Miodrag Ostojić, Nebojša Lalić, et al.. (2015). Risk factors clustering within the metabolic syndrome: a pattern or by chance?. PubMed. 55(2). 92–100. 6 indexed citations
16.
Miličić, Tanja, Aleksandra Jotić, Ivanka Marković, et al.. (2014). High Risk First Degree Relatives of Type 1 Diabetics: An Association with Increases in CXCR3+T Memory Cells Reflecting an Enhanced Activity of Th1 Autoimmune Response. International Journal of Endocrinology. 2014. 1–9. 2 indexed citations
17.
Jotić, Aleksandra, Vladimir Kostić, Katarina Lalić, et al.. (2013). Type 2 Diabetic Patients with Ischemic Stroke: Decreased Insulin Sensitivity and Decreases in Antioxidant Enzyme Activity Are Related to Different Stroke Subtypes. International Journal of Endocrinology. 2013. 1–7. 7 indexed citations
18.
19.
Lalić, Nebojša, Jelena Marić, Marina Svetel, et al.. (2008). Glucose Homeostasis in Huntington Disease. Archives of Neurology. 65(4). 476–476. 116 indexed citations
20.
Čolak, Emina, Nada Majkić‐Singh, Sanja Stanković, et al.. (2006). The effect of hyperglycemia on the values of antioxidative parameters in type 2 diabetic patients with cardiovascular complications. 25(2). 173–179. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Harvest F. Gu Breakdown of academic impact, for papers by Po‐Shiuan Hsieh Breakdown of academic impact, for papers by Thiago Bruder‐Nascimento Breakdown of academic impact, for papers by Avshalom Leibowitz Breakdown of academic impact, for papers by Ming-Sheng Zhou Breakdown of academic impact, for papers by Rocío Guzmán‐Ruiz Breakdown of academic impact, for papers by Xiao-Min Liu Breakdown of academic impact, for papers by PP Nawroth Breakdown of academic impact, for papers by Fabrizio Ceci
Rankless by CCL
2026